We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$1.08B
Cap. Flow
+$1.18B
Cap. Flow %
16.06%
Top 10 Hldgs %
55.65%
Holding
321
New
63
Increased
80
Reduced
61
Closed
90

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
ICLR icon
Icon
ICLR
+$97.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$87.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$82.5M
5
GSK icon
GSK
GSK
+$66.7M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$40.5M
2
PTCT icon
PTC Therapeutics
PTCT
+$36.7M
3
SHAK icon
Shake Shack
SHAK
+$32.9M
4
INCY icon
Incyte
INCY
+$30.5M
5
CYTK icon
Cytokinetics
CYTK
+$30.4M

Sector Composition

Rank Sector Weight
1 Healthcare 39.34%
2 Consumer Discretionary 6.39%
3 Consumer Staples 5.37%
4 Technology 5.27%
5 Communication Services 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXLIW
201
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$114K ﹤0.01%
325,000
– –
FEED
202
ENvue Medical Inc
FEED
$3.72M
$112K ﹤0.01%
1,721
-813
-32% -$54.8K
BCTXW
203
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$109K ﹤0.01%
375,000
– –
APCXW
204
DELISTED
AppTech Payments Corp Warrant
APCXW
$85.8K ﹤0.01%
715,000
– –
NXTC icon
205
NextCure
NXTC
$23.8M
$80.2K ﹤0.01%
8,667
+334
+4% +$4.91K
FGIWW
206
FGI Industries Warrant
FGIWW
$217K
$75.1K ﹤0.01%
933,333
– –
SQFTW icon
207
Presidio Property Trust Inc Series A Warrants
SQFTW
$217K
$69.8K ﹤0.01%
2,000,000
– –
BIAFW icon
208
bioAffinity Technologies
BIAFW
$68.7K ﹤0.01%
204,082
– –
VTAK icon
209
Catheter Precision
VTAK
$1.01M
$58.3K ﹤0.01%
6,798
+4,903
+259% +$42K
RVSNW icon
210
Rail Vision Ltd Warrant
RVSNW
$725K
$39.5K ﹤0.01%
136,187
– –
DRMA icon
211
Dermata Therapeutics
DRMA
$4.42M
$36.7K ﹤0.01%
+2,720
New +$35.1K
SNAX
212
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$22.6K ﹤0.01%
+35,139
New +$31.8K
SBEV.WS
213
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$17.3K ﹤0.01%
904,000
– –
SWAGW icon
214
Stran & Company Warrant
SWAGW
$66.4K
$6.81K ﹤0.01%
545,000
– –
IVDAW icon
215
Iveda Solutions Warrant
IVDAW
$47.8K
$3.9K ﹤0.01%
18,125
– –
SKYAW
216
SkyAI Inc
SKYAW
$263K
$2.15K ﹤0.01%
53,454
-1,122,546
-95% -$47.1K
KTTAW icon
217
Pasithea Therapeutics Warrants
KTTAW
$5.69K
$1.73K ﹤0.01%
50,000
– –
ACONW icon
218
Aclarion Warrant
ACONW
$49.4K
$688 ﹤0.01%
34,375
– –
BNCWW
219
CEA Industries Inc Warrant
BNCWW
$583 ﹤0.01%
58,333
– –
TNONW icon
220
Tenon Medical Inc Warrant
TNONW
$1.49K
$287 ﹤0.01%
22,250
– –
SVREW
221
SaverOne 2014 Ltd Warrant
SVREW
$269 ﹤0.01%
13,450
-228,650
-94% -$4.21K
AIMDW icon
222
Ainos Warrants
AIMDW
$80.7K
$249 ﹤0.01%
+5,000
New +$233
DFSCW
223
DEFSEC Technologies Warrant
DFSCW
$247 ﹤0.01%
12,000
-108,000
-90% -$2.5K
NLSPW
224
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$163 ﹤0.01%
12,500
– –
NEXRW
225
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$158 ﹤0.01%
5,284
-63,398
-92% -$2.37K
7 8
9
10 11

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Armistice Capital held 321 positions worth $7.33B, up 17% from $6.25B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital deployed $1.18B of net new capital in Q4 2024, opening 63 new positions and adding to 80 existing holdings. Its largest new stake was Exact Sciences: 1,617,000 shares worth $90.9M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was PTC Therapeutics, an estimated $36.7M trimmed.

  • Armistice Capital's largest Q4 2024 buy was Exact Sciences: 1,617,000 shares worth $90.9M.
  • Armistice Capital added most to Neurocrine Biosciences in Q4 2024, an estimated $87.9M increase.
  • Armistice Capital's biggest Q4 2024 reduction was PTC Therapeutics, cutting an estimated $36.7M.
  • Armistice Capital fully exited Alkermes in Q4 2024, selling an estimated $40.5M.
  • Armistice Capital's ten largest holdings make up 56% of its $7.33B portfolio in Q4 2024.
  • Armistice Capital opened 63 new positions and closed 90 in Q4 2024.
  • Armistice Capital's portfolio value rose 17% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.